Allsop David J, Dunlop Adrian J, Saddler Craig, Rivas Gonzalo R, McGregor Iain S, Copeland Jan
School of Psychology, University of Sydney, Sydney 2006, Australia.
Drug & Alcohol Clinical Services, Hunter New England Local Health District, New South Wales Ministry of Health, 2305, Australia; School of Medicine and Public Health, Faculty of Health, University of Newcastle, 2308, Australia.
Drug Alcohol Depend. 2014 May 1;138:54-60. doi: 10.1016/j.drugalcdep.2014.01.022. Epub 2014 Feb 12.
Cannabis causes lower mortality and morbidity than alcohol and tobacco so it is clinically important if quitting cannabis is associated with substitution with these substances. This study tests if cannabis is substituted with alcohol and/or tobacco during cannabis abstinence, and factors predicting such substitution.
A secondary analysis of a prospective community based study quantified cannabis, alcohol and tobacco use with Timeline Follow-back during a two-week voluntary cannabis abstinence and at one-month follow-up in non-treatment seeking cannabis users (n=45). Cannabis use was verified by urine THC-COOH levels.
Alcohol use increased by 8 standard units (SU; d=0.48)/week and cigarette use by 14 cigarettes/week (d=0.29) during cannabis abstinence. Those using less of each substance at baseline had greater increases during cannabis abstinence (alcohol P<0.0001, tobacco P=0.01). There was a decrease in alcohol (-4.8 SU, d=-0.29) and tobacco (-13 cigarettes/week, d=-0.26) use at follow-up, when most participants (87%, n=39) had resumed cannabis use. Increased cigarette use was predicted by cannabis withdrawal related sleep difficulty (insomnia) (P=0.05), restlessness (P=0.03) and physical symptoms (P=0.02). Neither alcohol nor cigarette use increased significantly in those (13.3%, n=6) who remained abstinent from cannabis through to follow-up.
Abstaining from cannabis was associated with increases in alcohol and tobacco use that decreased with resumption of cannabis use; however there were no increases in individuals who remained abstinent from cannabis at one-month follow-up. Tobacco use did not increase in those experiencing milder cannabis withdrawal symptoms. Research on substitution in treatment seekers during outpatient cannabis abstinence is needed.
大麻导致的死亡率和发病率低于酒精和烟草,因此,如果戒烟大麻与使用这些物质相互替代有关,那么这在临床上具有重要意义。本研究旨在测试在大麻戒断期间是否会用酒精和/或烟草替代大麻,以及预测这种替代的因素。
对一项基于社区的前瞻性研究进行二次分析,在两周的自愿大麻戒断期间以及在未寻求治疗的大麻使用者(n = 45)的一个月随访中,使用时间线追溯法对大麻、酒精和烟草的使用情况进行量化。通过尿液中四氢大麻酚 - 羧酸(THC - COOH)水平来验证大麻使用情况。
在大麻戒断期间,酒精使用量每周增加8标准单位(SU;效应量d = 0.48),香烟使用量每周增加14支(效应量d = 0.29)。在基线时每种物质使用量较少的人在大麻戒断期间增加量更大(酒精P < 0.0001,烟草P = 0.01)。在随访时,当大多数参与者(87%,n = 39)恢复使用大麻时,酒精(-4.8 SU,效应量d = -0.29)和烟草(-13支/周,效应量d = -0.26)的使用量有所下降。与大麻戒断相关的睡眠困难(失眠)(P = 0.05)、烦躁不安(P = 0.03)和身体症状(P = 0.02)可预测香烟使用量增加。在随访时仍保持大麻戒断的人(13.3%,n = 6)中,酒精和香烟的使用量均未显著增加。
戒除大麻与酒精和烟草使用量增加有关,而随着恢复使用大麻,这些使用量会下降;然而,在一个月随访时仍保持大麻戒断的个体中,使用量并未增加。大麻戒断症状较轻的人烟草使用量未增加。需要对门诊大麻戒断期间寻求治疗者的替代情况进行研究。